Search Results

There are 16227 results for: content related to: Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer

  1. You have free access to this content
    Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E635–E640, Matthias M. Heck, Mark Thalgott, Margitta Retz, Petra Wolf, Tobias Maurer, Roman Nawroth, Georgios Hatzichristodoulou, Jürgen E. Gschwend and Hubert Kübler

    Version of Record online : 13 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11364.x

  2. Docetaxel-Associated Epiphora

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 6, June 2006, Pages: 853–867, Dr. Polly E. Kintzel, Dr. Laura B. Michaud and Dr. Marianne K. Lange

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.6.853

  3. You have free access to this content
    Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer

    BJU International

    Volume 107, Issue 2, January 2011, Pages: 234–239, Giuseppe Di Lorenzo, Carlo Buonerba, Adriana Faiella, Pasquale Rescigno, Mimma Rizzo, Riccardo Autorino, Sisto Perdonà, Nando Riccardi, Sarah Scagliorini, Florinda Scognamiglio, Daniele Masala, Matteo Ferro, Giovannella Palmieri, Michele Aieta, Alfredo Marinelli, Vincenzo Altieri, Sabino De Placido and Giacomo Cartenì

    Version of Record online : 29 JUN 2010, DOI: 10.1111/j.1464-410X.2010.09498.x

  4. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x

  5. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  6. Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer

    Veterinary and Comparative Oncology

    Volume 12, Issue 2, June 2014, Pages: 160–168, A. Waite, C. Balkman, D. Bailey, M. Kiselow, A. Flory, B. B. Beaulieu, L. D. Lewis and M. McEntee

    Version of Record online : 21 AUG 2012, DOI: 10.1111/j.1476-5829.2012.00350.x

  7. Chemotherapy for the treatment of hormone-refractory prostate cancer

    International Journal of Clinical Practice

    Volume 61, Issue 12, December 2007, Pages: 2064–2070, S. Chowdhury, S. Burbridge and P. G. Harper

    Version of Record online : 23 OCT 2007, DOI: 10.1111/j.1742-1241.2007.01551.x

  8. You have free access to this content
    Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 974–978, Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill and Philippe Beuzeboc

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09296.x

  9. Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

    The Journal of Gene Medicine

    Volume 12, Issue 6, June 2010, Pages: 516–527, Xiong Li, Youhong Liu, Yong Tang, Phipps Roger, Meei-Huey Jeng and Chinghai Kao

    Version of Record online : 17 MAY 2010, DOI: 10.1002/jgm.1462

  10. You have free access to this content
    Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer

    BJU International

    Volume 115, Issue 5, May 2015, Pages: 744–752, Stéphane Oudard, Gero Kramer, Orazio Caffo, Lorraine Creppy, Yohan Loriot, Steinbjoern Hansen, Mats Holmberg, Frederic Rolland, Jean-Pascal Machiels and Michael Krainer

    Version of Record online : 29 DEC 2014, DOI: 10.1111/bju.12845

  11. You have free access to this content
    The role of docetaxel based therapy for prostate cancer in the era of targeted medicine

    International Journal of Urology

    Volume 17, Issue 3, March 2010, Pages: 228–240, Guru Sonpavde and Cora N Sternberg

    Version of Record online : 19 JAN 2010, DOI: 10.1111/j.1442-2042.2010.02449.x

  12. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptotic Pathway During Chemotherapy in Bone Marrow

    Journal of Cellular Biochemistry

    Accepted manuscript online: 5 MAY 2016, Eunsohl Lee, Ann M. Decker, Frank C. Cackowski, Lulia A. Kana, Kenji Yumoto, Younghun Jung, Jingcheng Wang, Laura Buttitta, Todd M. Morgan and Russell S. Taichman

    DOI: 10.1002/jcb.25582

  13. You have free access to this content
    The effect of Echinacea purpurea on the pharmacokinetics of docetaxel

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 467–474, Andrew K. L. Goey, Irma Meijerman, Hilde Rosing, Jacobus A. Burgers, Marja Mergui-Roelvink, Marianne Keessen, Serena Marchetti, Jos H. Beijnen and Jan H. M. Schellens

    Version of Record online : 20 AUG 2013, DOI: 10.1111/bcp.12159

  14. You have free access to this content
    Current and emerging treatment modalities for metastatic castration-resistant prostate cancer

    BJU International

    Volume 107, Issue s2, April 2011, Pages: 13–20, Sergio Bracarda, Christopher Logothetis, Cora N. Sternberg and Stéphane Oudard

    Version of Record online : 7 MAR 2011, DOI: 10.1111/j.1464-410X.2010.10036.x

  15. Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancer

    Internal Medicine Journal

    Volume 35, Issue 8, August 2005, Pages: 468–472, A. M. Joshua, 1 I. Nordman, 1 R. Venkataswaran, 2 S. Clarke, 1 M. R. Stockler and 1,3 M. J. Boyer 1

    Version of Record online : 26 JUL 2005, DOI: 10.1111/j.1445-5994.2005.00883.x

  16. You have free access to this content
    A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3283–3293, Angeles Alvarez Secord, Andrew Berchuck, Robert V. Higgins, Lawrence R. Nycum, Matthew F. Kohler, Larry E. Puls, Robert W. Holloway, George S. Lewandowski, Fidel A. Valea and Laura J. Havrilesky

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26610

  17. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity

    The Prostate

    Volume 72, Issue 6, 1 May 2012, Pages: 661–667, Peter Makhov, Konstantin Golovine, Daniel Canter, Alexander Kutikov, Jay Simhan, Melany M. Corlew, Robert G. Uzzo and Vladimir M. Kolenko

    Version of Record online : 27 JUL 2011, DOI: 10.1002/pros.21469

  18. You have free access to this content
    Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel

    International Journal of Cancer

    Volume 125, Issue 11, 1 December 2009, Pages: 2728–2736, Lysann Sauer, Joao Nunes, Vishal Salunkhe, Lenka Skalska, Takafumi Kohama, Olivier Cuvillier, Jonathan Waxman and Dmitry Pchejetski

    Version of Record online : 11 JUN 2009, DOI: 10.1002/ijc.24640

  19. You have free access to this content
    Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer

    Cancer

    Volume 110, Issue 9, 1 November 2007, Pages: 2027–2034, John D. Hainsworth, David R. Spigel, Cindy Farley, Dianna L. Shipley, James D. Bearden, Jitendra Gandhi, Gerry Ann Houston and F. Anthony Greco

    Version of Record online : 6 SEP 2007, DOI: 10.1002/cncr.23019

  20. You have free access to this content
    Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma

    Cancer

    Volume 92, Issue 9, 1 November 2001, Pages: 2391–2398, John D. Hainsworth, Howard A. Burris III, Frederic T. Billings III, James E. Bradof, Margaret Baker and F. Anthony Greco

    Version of Record online : 23 OCT 2001, DOI: 10.1002/1097-0142(20011101)92:9<2391::AID-CNCR1587>3.0.CO;2-M